DnB Asset Management AS Increases Stake in Boston Scientific Corporation (BSX)

The shares were sold at an average price of $28.22, for a total transaction of $282,200.00. Following the transaction, the senior vice president now owns 24,201 shares in the company, valued at approximately $671,335.74. The company has market cap of $24.29 billion. Its up 0.01, from 1.03 in 2017Q2. About 56,240 shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since January 11, 2017 and is uptrending. It has underperformed by 7.29% the S&P500. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Iguana Healthcare Management Llc bought 70,000 shares as the company's stock rose 4.02% with the market. Cullinan Assocs Incorporated accumulated 198,602 shares or 0.82% of the stock. The business's quarterly revenue was up 5.6% on a year-over-year basis.

The counter witnessed a trading volume of 0.79 million shares versus an average volume of 0.55 million shares during last trading session. About 129,059 shares traded or 17.01% up from the average.

The opening price for Boston Scientific Corporation (NYSE:BSX) was $27.7 and the volume amounted to 13.01 million shares which compares with the average volume of 8.72 million shares. It has outperformed by 2.42% the S&P500.

Investors sentiment increased to 1.35 in Q3 2017.

Since October 3, 2017, it had 0 insider purchases, and 1 sale for $575,000 activity.

A number of other institutional investors also recently added to or reduced their stakes in the stock. 118 funds opened positions while 525 raised stakes. It also upped Park Sterling Corp (NASDAQ:PSTB) stake by 76,633 shares and now owns 129,405 shares. Macquarie Grp Ltd holds 33,000 shares or 0% of its portfolio. Moreover, David R Rahn Associates Inc has 0.52% invested in General Electric Company (NYSE:GE). Ibm Retirement Fund holds 0.2% or 34,311 shares in its portfolio. Alphamark Advsrs Ltd Liability Corporation accumulated 200 shares. About 3.54 million shares traded. Verity Asset Management owns 7,167 shares or 0.15% of their U.S. portfolio. The hedge fund run by Philippe Laffont held 3.04 million shares of the television services company at the end of 2017Q3, valued at $99.53M, down from 3.52M at the end of the previous reported quarter. Hudock Group Ltd Limited Liability Company holds 0.1% in U.S. Bancorp (NYSE:USB) or 3,820 shares. Kemnay Advisory holds 1,900 shares. Parkside Bank And holds 17 shares or 0% of its portfolio. Mufg Americas Hldgs Corporation invested 0% in Boston Scientific Corporation (NYSE:BSX). Tarbox Family Office reported 377 shares. Tower Capital (Trc) has 0% invested in Sarepta Therapeutics, Inc. Oppenheimer & Company invested 0.86% of its portfolio in General Electric Company (NYSE:GE). (NYSE:C), 19 have Buy rating, 3 Sell and 16 Hold. Therefore 100% are positive. Boston Scientific Corporation had 83 analyst reports since July 27, 2015 according to SRatingsIntel. $440,547 worth of stock was sold by Phalen Michael P. on Monday, October 30. Oppenheimer maintained the shares of BSX in report on Wednesday, June 28 with "Hold" rating. The firm earned "Buy" rating on Thursday, August 20 by Roth Capital. On Monday, September 28 the stock rating was upgraded by Global Hunter Securities to "Accumulate". The firm has "Buy" rating by Stifel Nicolaus given on Wednesday, November 29. As per Thursday, February 25, the company rating was initiated by Suntrust Robinson. The firm has "Outperform" rating by Credit Suisse given on Thursday, October 5. The rating was downgraded by Standpoint Research on Tuesday, January 10 to "Hold". The firm has "Sell" rating by Deutsche Bank given on Tuesday, November 21. The Marco Investment Management Llc holds 2,672 shares with $412,000 value, down from 6,627 last quarter.

Since August 1, 2017, it had 0 insider buys, and 11 selling transactions for $14.78 million activity. Comstock Elizabeth J sold $633,375 worth of General Electric Company (NYSE:GE) on Wednesday, August 9. Its last month's stock price volatility remained 2.58% which for the week stands at 1.67%. Among active positions in the latest quarter, 237 holders increased their positions by a total of 50.69 million shares, 247 holders decreased the positions by a total of 44.34 million shares, and 103 holders held their positions. BSX's profit will be $466.89M for 20.17 P/E if the $0.34 EPS becomes a reality.

Facebook, Inc. (FB) in the last quarter reported its actual EPS of $1.59/share where the analyst estimated EPS was $1.28/share.

Among 29 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. $208,328 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Sorenson John Bradley on Wednesday, August 2. Boston Scientific Corporation has a 1 year low of $23.03 and a 1 year high of $29.93. The rating was maintained by RBC Capital Markets on Thursday, April 28 with "Outperform". The company presently has a consensus rating of "Buy" and an average target price of $31.00. JP Morgan initiated the stock with "Overweight" rating in Thursday, December 22 report. RBC Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, June 9.

Boston Scientific Corporation (BSX) failed to surprise the stock market in its last reported earnings when it earned $0.31 a piece versus the consensus-estimated $0.31. Finally, Canaccord Genuity dropped their price target on shares of Boston Scientific from $36.00 to $35.00 and set a "buy" rating on the stock in a research note on Wednesday, November 29th.

Redmile Group Llc increased Clovis Oncology Inc (NASDAQ:CLVS) stake by 844,610 shares to 996,610 valued at $82.12 million in 2017Q3. It also increased its holding in Jd Com Inc (NASDAQ:JD) by 71,050 shares in the quarter, for a total of 12.64 million shares, and has risen its stake in Alibaba Group Hldg Ltd (NYSE:BABA).

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Notícias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.